Catherine M Burzik is Director of HAEMONETICS CORP. Currently has a direct ownership of 19,545 shares of HAE, which is worth approximately $1.4 Million. The most recent transaction as insider was on Aug 05, 2022, when has been sold 2,730 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.5K
0% 3M change
0% 12M change
Total Value Held $1.4 Million

CATHERINE M BURZIK Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 05 2022
BUY
Grant, award, or other acquisition
-
2,730 Added 12.26%
19,545 Common Stock
Aug 06 2021
BUY
Grant, award, or other acquisition
-
3,077 Added 15.47%
16,815 Common Stock

Also insider at

BDX
BECTON DICKINSON & CO Healthcare
OFIX
Orthofix Medical Inc. Healthcare
CMB

Catherine M Burzik

Director
Boston, MA

Track Institutional and Insider Activities on HAE

Follow HAEMONETICS CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HAE shares.

Notify only if

Insider Trading

Get notified when an Haemonetics Corp insider buys or sells HAE shares.

Notify only if

News

Receive news related to HAEMONETICS CORP

Track Activities on HAE